Jean-Philippe Jacquin

2.8k total citations
37 papers, 774 citations indexed

About

Jean-Philippe Jacquin is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jean-Philippe Jacquin has authored 37 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 14 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jean-Philippe Jacquin's work include Cancer Treatment and Pharmacology (15 papers), Breast Cancer Treatment Studies (12 papers) and Cancer survivorship and care (7 papers). Jean-Philippe Jacquin is often cited by papers focused on Cancer Treatment and Pharmacology (15 papers), Breast Cancer Treatment Studies (12 papers) and Cancer survivorship and care (7 papers). Jean-Philippe Jacquin collaborates with scholars based in France, United Kingdom and United States. Jean-Philippe Jacquin's co-authors include Silvy Laporte, P. Fournel, Nicolas Magné, Daniel Serin, Pierre Kerbrat, P. Fumoleau, Franck Chauvin, Andrew Kramar, María Rios and X. Pivot and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jean-Philippe Jacquin

35 papers receiving 751 citations

Peers

Countries citing papers authored by Jean-Philippe Jacquin

Since Specialization

Citations

This map shows the geographic impact of Jean-Philippe Jacquin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-Philippe Jacquin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-Philippe Jacquin more than expected).

Fields of papers citing papers by Jean-Philippe Jacquin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-Philippe Jacquin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-Philippe Jacquin. The network helps show where Jean-Philippe Jacquin may publish in the future.

Co-authorship network of co-authors of Jean-Philippe Jacquin

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-Philippe Jacquin. A scholar is included among the top collaborators of Jean-Philippe Jacquin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-Philippe Jacquin. Jean-Philippe Jacquin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane 2024 ·British Journal of Cancer ·Hélène Vanacker, Isabelle Treilleux, Camille Schiffler, Ivan Bièche, Mario Campone, Anne Patsouris, Mónica Arnedos, Paul Cottu, Jean-Philippe Jacquin, Florence Dalenc, (unknown), Nicolas Servant, Valéry Attignon, Étienne Rouleau, Alain Morel, (unknown), Marta Jimenez, Fabrice André, Thomas Bachelot	0
2	Safety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERmione non-interventional prospective study 2019 ·The Breast ·Jean-Philippe Jacquin, Lionel Uwer, Alexia Savignoni, Jean-Marc Ferrero, Alain Lortholary, (unknown), (unknown), Nasséra Chalabi, (unknown), Yazid Belkacémi	5
3	Syndrome d’encéphalopathie postérieure réversible : à propos de 4 cas 2019 ·La Presse Médicale ·(unknown), Wafa Bouleftour, Romain Rivoirard, (unknown), (unknown), Jean-Philippe Jacquin, P. Fournel, Benoîte Méry, (unknown)	2
4	Analogues de la LH-RH dans le traitement hormonal adjuvant dans les cancers du sein localisés de la femme pré-ménopausée : la fin d’une controverse pour de nouvelles recommandations ? 2019 ·Bulletin du Cancer ·Élisabeth Daguenet, (unknown), Alexis Vallard, Jean‐Baptiste Guy, Jean-Philippe Jacquin, Benoîte Méry, Nicolas Magné	1
5	Perception des effets indésirables de la chimiothérapie et de l’hormonothérapie par les femmes prises en charge pour un cancer du sein 2016 ·Therapies ·(unknown), Jean-Philippe Jacquin, (unknown)	3
6	Improving Adherence to Adjuvant Endocrine Therapy in Breast Cancer Through a Therapeutic Educational Approach: A Feasibility Study 2016 ·Oncology nursing forum ·Aurélie Bourmaud, (unknown), Véronique Régnier Denois, Olivier Collard, Jean-Philippe Jacquin, Yacine Merrouche, (unknown), Fabien Tinquaut, (unknown), Franck Chauvin	12
7	Social inequalities and cancer: can the European deprivation index predict patients' difficulties in health care access? a pilot study 2015 ·Oncotarget ·(unknown), Aurélie Bourmaud, Fabien Tinquaut, Mathieu Oriol, Jean-Philippe Jacquin, P. Fournel, Nicolas Magné, Franck Chauvin	25
8	Réentraînement à l’activité physique dans la prise en charge globale du cancer du sein : étude pilote monocentrique 2014 ·Bulletin du Cancer ·(unknown), Jane‐Chloé Trone, Benoîte Méry, Jean-Baptiste Guichard, Romain Rivoirard, (unknown), Jean‐Baptiste Guy, (unknown), Olivier Collard, (unknown), Jean-Philippe Jacquin, (unknown), Nicolas Magné	0
9	6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial 2013 ·The Lancet Oncology ·X. Pivot, Gilles Romieu, Marc Debled, Jean‐Yves Pierga, Pierre Kerbrat, Thomas Bachelot, Alain Lortholary, Marc Espié, P. Fumoleau, Daniel Serin, Jean-Philippe Jacquin, Christelle Jouannaud, María Rios, Sophie Abadie‐Lacourtoisie, N. Tubiana-Mathieu, Laurent Cany, Stéphanie Catala, David Khayat, Iris Pauporté, Andrew Kramar	211
10	Prise en charge du cancer primitif du vagin chez la femme de plus de 70ans : intérêt d’une association radiothérapie-curiethérapie 2013 ·La Presse Médicale ·Coralie Moncharmont, Antonin Lévy, Jean‐Baptiste Guy, Pierre Auberdiac, (unknown), (unknown), Cyrus Chargari, (unknown), Jean-Philippe Jacquin, Céline Chauleur, Guy de Laroche, Nicolas Magné	1
11	Uterine and Ovary Carcinosarcomas 2013 ·American Journal of Clinical Oncology ·(unknown), Aurélie Bourmaud, Romain Rivoirard, (unknown), Jean‐Baptiste Guy, Olivier Collard, (unknown), Jean-Philippe Jacquin, Antonin Lévy, Céline Chauleur, Nicolas Magné, Yacine Merrouche	18
12	Mise en place d'une étude pilote de sensibilisation au réentraînement à l'activité physique dans deux populations sélectionnées atteintes d'un cancer du sein 2012 ·Bulletin du Cancer ·(unknown), Antonin Lévy, Jean-Baptiste Guichard, Martin Garet, Pierre Auberdiac, Frédéric Roche, (unknown), Coralie Moncharmont, Jean-Philippe Jacquin, Guy de Laroche, Nicolas Magné	4
13	Sarcoma of vulva, vagina and ovary 2011 ·Best Practice & Research Clinical Obstetrics & Gynaecology ·Nicolas Magné, (unknown), Pierre Auberdiac, Jean-Philippe Jacquin, Cyrus Chargari, Céline Chauleur, Christine Meder, Yacine Merrouche	21
14	Recommendations for a lifestyle which could prevent breast cancer and its relapse: Physical activity and dietetic aspects 2011 ·Critical Reviews in Oncology/Hematology ·Nicolas Magné, (unknown), Cyrus Chargari, Pierre Castadot, Jean-Baptiste Guichard, (unknown), Alice Nourissat, Rémy Largillier, Jean-Philippe Jacquin, Franck Chauvin, Yacine Merrouche	32
15	Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: Results of an observational study 2011 ·Critical Reviews in Oncology/Hematology ·Gilles Freyer, Mario Campone, Julien Péron, T. Facchini, C. Terret, Jean-François Berdah, Jean-Philippe Jacquin, David Coeffic, (unknown), Claire Falandry	28
16	Quantification de l’activité physique journalière des patientes traitées pour un cancer du sein et comparaison avec deux populations témoins 2011 ·Bulletin du Cancer ·Jean-Baptiste Guichard, Martin Garet, Pierre Auberdiac, Alice Nourissat, Frédéric Roche, (unknown), Jean Barthélemy, Franck Chauvin, Antoine Da Costa, Cyrus Chargari, Yacine Merrouche, Jean-Philippe Jacquin, Olivier Collard, Nicolas Magné	6
17	Phase II Trial of Pegylated Liposomal Doxorubicin in Combination With Gemcitabine in Metastatic Breast Cancer Patients 2011 ·American Journal of Clinical Oncology ·Jean-Philippe Jacquin, Cyrus Chargari, (unknown), (unknown), (unknown), Hubert Orfeuvre, (unknown), L. Chaigneau, Alice Nourissat, (unknown), J. Savary, Yacine Merrouche, Nicolas Magné	11
18	Treatment of Metastatic Breast Cancer 2009 ·American Journal of Clinical Oncology ·Bénédicte Poncet, Cyrille Colin, Thomas Bachelot, (unknown), (unknown), Laurent Magaud, (unknown), Mireille Mousseau, J Tigaud, Jean-Philippe Jacquin, V. Trillet-Lenoir	15
19	A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study 2007 ·Breast Cancer Research and Treatment ·Philippe A. Cassier, Sylvie Chabaud, V. Trillet-Lenoir, (unknown), J Tigaud, Hervé Curé, Hubert Orfeuvre, Bruno César Corrêa Salles, C. Martin, Jean-Philippe Jacquin, (unknown), Jean‐Paul Guastalla, David Pérol, Thomas Bachelot	32
20	Postmenopausal Patients with Node-Positive Resectable Breast Cancer 1993 ·Drugs ·J.P. Gérard, Michel Héry, D Gedouin, Alain Monnier, Marie-Josèphe Goudier, Jean-Philippe Jacquin, (unknown), (unknown), D. Serin, M. Namer, (unknown), P Hurteloup	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact